Skip to content

Insider · CIK 0001900772

James William Burns

officer

Files at AGIO (AGIOS PHARMACEUTICALS, INC.). First filing Nov 12, 2024, latest Jun 26, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $1.4M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AGIO: AGIOS PHARMACEUTICALS, INC.

AGIOOct 9, 2026 · close 31.81

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
5Weak
AGIOsell 510b5-1
AGIOS PHARMACEUTICALS, INC.
$94k
2,799 shares
-9%+36% from low-46% from high
11Weak
AGIOsell 610b5-1
AGIOS PHARMACEUTICALS, INC.
$142k
4,005 shares
-20%+4% from low-46% from high
55Moderate
AGIOsell 310b5-1
AGIOS PHARMACEUTICALS, INC.
$1.1M
21,752 shares
-58%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock10b5-1
+6,000$0.00$031,449Jun 26, 2025
Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-2,799$33.54$94k28,650Jun 26, 2025
Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Performance share unitsderivative10b5-1
-6,000$0.00$06,000Jun 26, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock10b5-1
+3,833$0.00$019,787Mar 4, 2025
Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-1,137$35.54$40k18,650Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock10b5-1
+4,000$0.00$022,650Mar 4, 2025
Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-1,187$35.54$42k21,463Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock10b5-1
+5,667$0.00$027,130Mar 4, 2025
Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-1,681$35.54$60k25,449Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AGrant or award
Restricted stock unitsderivative10b5-1
+12,000$0.00$012,000Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AGrant or award
Restricted stock unitsderivative10b5-1
+11,759$0.00$011,759Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AGrant or award
Stock options (right to buy)derivative10b5-1
+43,500$0.00$043,500Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Restricted stock unitsderivative10b5-1
-3,833$0.00$00Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Restricted stock unitsderivative10b5-1
-4,000$0.00$04,000Mar 4, 2025
Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Restricted stock unitsderivative10b5-1
-5,667$0.00$011,333Mar 4, 2025
Nov 7, 2024AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-13,411$52.00$697k24,041Nov 12, 2024
Nov 7, 2024AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-8,341$52.56$438k15,700Nov 12, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

James William Burns: insider trades and track record | InsiderTell